Kazia Therapeutics is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. Headquartered in Sydney, Australia, Kazia Therapeutics collaborates with leading scientists, clinicians, and investors around the world.
Alterity Therapeutics
Parkville, Australia · Post IPO Equity
Benitec Biopharma
Balmain, Australia · Post IPO Equity
DroneShield
Sydney, Australia · Post IPO Equity
Vow
Sydney, Australia · Series A
Organicell
Miami Beach, United States · Post IPO Equity
Kadimastem
Ness Ziona, Israel · IPO
Pacific Edge
Dunedin, New Zealand · Post IPO Equity
89bio
San Francisco, United States · Post IPO Equity
Day One Biopharmaceuticals
South San Francisco, United States · Post IPO Equity
Gemini Therapeutics
Cambridge, United States · Post IPO Equity
Mereo BioPharma
New York, United States · Post IPO Equity
Nuheara
Northbridge, Australia · IPO